Skip to main content

Advertisement

SpringerLink
Log in

Treatment of Childhood Tuberculosis

  • SYMPOSIUM ON PEDIATRIC TUBERCULOSIS
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

The aim of tuberculosis treatment is to cure the individual patient with antituberculosis drugs (ATT) in a short time without emergence of drug resistance. The anti tuberculosis drugs are selected in a combination to attack all the subpopulations of tubercle bacilli with first line drugs which include isoniazid, rifampicin, pyrazinamide, and ethambutol. Intermittent ATT regimens have been documented to be as effective as daily regimen. World Health Organization (WHO) has suggested a category based treatment of tuberculosis given in two phases, intensive phase and continuation phase. As per WHO, Revised National Tuberculosis Control Programme (RNTCP) recommends directly observed therapy short course strategy (DOTS) for the treatment of both adult and pediatric tuberculosis. In DOTS the patient is asked to swallow ATT under the direct observation of health personnel. Drug dosage for daily and intermittent therapy varies. To simplify the prescription, fixed drug combination (FDC) and patient-wise boxes (PWB) are available under RNTCP, free of cost. Each patient’s management plan should be individualized to incorporate measures that facilitate adherence. The knowledge of drug resistant tuberculosis, HIV-related tuberculosis, and latent tuberculosis infection are the areas that need to be updated. Private practioners may play a significant role by referring the children with tuberculosis to the DOTS centers early which will not only benefit the affected family but also the society.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Murray, Christopher JL, Lopez, Alan D. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020: summary – WHO Geneva, Switzerland, 1996; W 74 96GL-1/1996.

  2. Simone PM, Fujiwara PI. Role of the health department: legal and public health implications. In: Schlossberg D, editor. Tuberculosis and nontuberculous mycobacterial infections. 4th ed. Philadelphia: W.B. Saunders; 1999. p. 130–9.

    Google Scholar 

  3. WHO. Treatment of tuberculosis. Guidelines for National Programmes. Geneva: WHO; 2003 (WHO/CDS/TB 2003; 313).

  4. Mitchison DA. Mechanisms of the action of drugs in short-course chemotherapy. Bull Int Union Tuberc. 1985;60:36–40.

    PubMed  CAS  Google Scholar 

  5. David HL. Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis. Appl Microbiol. 1970;20:810–4.

    PubMed  CAS  Google Scholar 

  6. Working Group on Tuberculosis, Indian Academy of Pediatrics (IAP). Recommendations - Consensus statement on childhood tuberculosis. Indian Pediatr. 2010;47:41–55.

    Article  Google Scholar 

  7. Te Water Naude JM, Donald PR, Hussey GD, et al. Twice weekly vs daily chemotherapy for childhood tuberculosis. Pediatr Infect Dis J. 2000;19:405–10.

    Article  PubMed  CAS  Google Scholar 

  8. Kabra SK, Lodha R, Seth V. Category based treatment of tuberculosis in children, brief report. Indian Pediatr. 2004;41:931–6.

    Google Scholar 

  9. Chauhan LS, Arora VK. Management of pediatric tuberculosis under the revised national tuberculosis control programme. Indian J Pediatr. 2004;71:341–3.

    Article  PubMed  CAS  Google Scholar 

  10. Kumar P. Journey of tuberculosis control movement in India: national tuberculosis control program to revised national tuberculosis control program. Indian J Tuberc. 2005;S2:63–71.

    Google Scholar 

  11. Kelkar-Khambate A, Klelmann K, Pawar S, et al. India’s revised national tuberculosis control program: looking beyond detection and cure. Int J Tuberc Lung Dis. 2008;12:87–92.

    Google Scholar 

  12. Mandalakas AM, Strake JR. Tuberculosis and Nontuberculous Mycobacterial Disease. In: Chernick V, Boat TF, Wilmot RW, Bush A, editors. Kendig’s diseases of the Respiratory Tract in Children, 1998; pp 507–529.

  13. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med. 2000;161:S221–247.

    Google Scholar 

  14. Donald PR. Children and protecting the next generation? Lancet. 1999;353:1001–2.

    Article  PubMed  CAS  Google Scholar 

  15. Nelson LJ, Jereb JA, Castro KG. New guidelines about latent tuberculosis infection in children and adolescents: a welcome advancement. Pediatrics. 2004;114:1084–6.

    Article  PubMed  Google Scholar 

  16. Revised National Tuberculosis Control Programme (RNTCP) Training Module for Medical Practitioners, Central TB Division Directorate General of Health Services Ministry of Health and Family Welfare Nirman Bhawan New Delhi 110 01 (June 2006).

  17. Singh M. Adherence to anti-tuberculosis treatment. Indian Pediatr. 1999;36:1285–6.

    PubMed  CAS  Google Scholar 

  18. Kabra SK, Lodha R, Seth V. Tuberculosis in children-what has changed in last 20 years? Indian J Pediatr. 2002;69 Suppl 1:S5–10.

    PubMed  Google Scholar 

  19. Drobniewski FA, Balabanova YM. The diagnosis and management of multiple-drug-resistant-tuberculosis at the beginning of the new millenium. Int J Infect Dis. 2002;6:S21–31.

    Article  PubMed  Google Scholar 

  20. Swaminathan S, Datta M, Radhamani M, et al. A profile of bacteriologically confirmed pulmonary tuberculosis in children. Indian Pediatr. 2008;45:745.

    Google Scholar 

  21. Schaaf HS, Van Rie A, Gie RP, et al. Transmission of multi drug-resistant tuberculosis. Pediatr Infect Dis J. 2000;19:695–9.

    PubMed  CAS  Google Scholar 

  22. Dupon M, Texier-Maugein J, Leroy V, et al. Tuberculosis and HIV infection: a cohort study of incidence and susceptibility to antituberculosis drugs, Bordeaux, 1985–1993. AIDS. 1995;9:577–83.

    Article  PubMed  CAS  Google Scholar 

  23. Kabra SK, Lodha R, Seth V. Review Article- Some current concepts on childhood tuberculosis. Indian J Med Res. 2004;120:387–97.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. HOD, Department of Pulmonology (Pediatric Respiratory diseases), Institute of Child Health and Hospital for Children, Egmore, , Chennai, 600008, India

    D. Vijayasekaran

  2. No: 4, Third Street, Dr Subbarayan Nagar, Kodambakkam, Chennai, 600024, India

    D. Vijayasekaran

Authors
  1. D. Vijayasekaran
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. Vijayasekaran.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vijayasekaran, D. Treatment of Childhood Tuberculosis. Indian J Pediatr 78, 443–448 (2011). https://doi.org/10.1007/s12098-010-0273-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-010-0273-0

Keywords

Search

Navigation